Wei Wang
- Cancer Research top 0.5%
- MicroRNA in disease regulation 21
- Obstetrics and Gynecology top 0.5%
- Pregnancy and preeclampsia studies 30
- Immunology top 1%
- Immune Cell Function and Interaction 34
- Oncology top 0.5%
- Cancer-related Molecular Pathways 35
- Drug Transport and Resistance Mechanisms 29
- Cancer Cells and Metastasis 20
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 37
-
- Cervical Cancer and HPV Research 30
- Co-authors
- Nazzareno BallatoriXiao Peng ZhangFeng LiuDavid C. ZawiejaDing MaXiao‐Peng ZhangChenfei ZhouBing‐Hao Luo
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Wang
385 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 2.2k
- Obstetrics and Gynecology 927
- Immunology 2.2k
- Oncology 2.7k
- Immunology and Allergy 441
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 36 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 5 | |
| 10 | Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based studybreakdown → | 2021 | 193 |
| 11 | Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis | 2019 | 1 |
| 12 | 2019 | 19 | |
| 13 | 2018 | 12 | |
| 14 | 2018 | 86 | |
| 15 | Study on the correlation between ultrasonic imaging features in breast cancer and the expression of ER, PR, HER-2 and nm23 | 2017 | 1 |
| 16 | 2015 | 4 | |
| 17 | 2014 | 75 | |
| 18 | 2012 | 141 | |
| 19 | 2009 | 14 | |
| 20 | Fine structure, genome and polypeptides of a grass carp hemorrhage virus (GCHV) isolate from the South Lake in Wuhan. | 1990 | 1 |
About Wei Wang
Wei Wang is a scholar working on Immunology and Allergy, Obstetrics and Gynecology and Oncology, having authored 403 papers that have together received 10.5k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (37 papers), Cancer-related Molecular Pathways (35 papers), Immune Cell Function and Interaction (34 papers), Pregnancy and preeclampsia studies (30 papers), Cervical Cancer and HPV Research (30 papers), Drug Transport and Resistance Mechanisms (29 papers), MicroRNA in disease regulation (21 papers) and Cancer Cells and Metastasis (20 papers). The work is most often cited by research in Cancer Research (2.2k citations), Obstetrics and Gynecology (927 citations) and Immunology (2.2k citations). Wei Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Nazzareno Ballatori, Xiao Peng Zhang, Feng Liu, David C. Zawieja, Ding Ma, Xiao‐Peng Zhang, Chenfei Zhou, Bing‐Hao Luo, Shixuan Wang and Sha Wu. Their work appears in journals such as PLoS ONE, Journal of Biological Chemistry, Hypertension, The Journal of Immunology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.